Division of Cardiology, Department of Medicine, and Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois (N.S.S., S.S.K.).
Division for Heart Disease and Stroke Prevention, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, and Bizzell Group, Atlanta, Georgia (C.L.).
Ann Intern Med. 2022 Nov;175(11):1493-1500. doi: 10.7326/M22-0609. Epub 2022 Oct 4.
Obesity increases the risk for metabolic and cardiovascular disease, and this risk occurs at lower body mass index (BMI) thresholds in Asian adults than in White adults. The degree to which obesity prevalence varies across heterogeneous Asian American subgroups is unclear because most obesity estimates combine all Asian Americans into a single group.
To quantify obesity prevalence in Asian American subgroups among U.S. adults using both standard BMI categorizations and categorizations tailored to Asian populations.
Cross-sectional.
United States, 2013 to 2020.
The analytic sample included 2 882 158 adults aged 18 years or older in the U.S. Behavioral Risk Factor Surveillance System surveys (2013 to 2020). Participants self-identified as non-Hispanic White ([NHW] = 2 547 965); non-Hispanic Black ([NHB] = 263 136); or non-Hispanic Asian ([NHA] = 71 057), comprising Asian Indian ( = 13 916), Chinese ( = 11 686), Filipino ( = 11 815), Japanese ( = 12 473), Korean ( = 3634), and Vietnamese ( = 2618) Americans.
Obesity prevalence adjusted for age and sex calculated using both standard BMI thresholds (≥30 kg/m) and BMI thresholds modified for Asian adults (≥27.5 kg/m), based on self-reported height and weight.
Adjusted obesity prevalence (by standard categorization) was 11.7% (95% CI, 11.2% to 12.2%) in NHA, 39.7% (CI, 39.4% to 40.1%) in NHB, and 29.4% (CI, 29.3% to 29.5%) in NHW participants; the prevalence was 16.8% (CI, 15.2% to 18.5%) in Filipino, 15.3% (CI, 13.2% to 17.5%) in Japanese, 11.2% (CI, 10.2% to 12.2%) in Asian Indian, 8.5% (CI, 6.8% to 10.5%) in Korean, 6.5% (CI, 5.5% to 7.5%) in Chinese, and 6.3% (CI, 5.1% to 7.8%) in Vietnamese Americans. The prevalence using modified criteria (BMI ≥27.5 kg/m) was 22.4% (CI, 21.8% to 23.1%) in NHA participants overall and 28.7% (CI, 26.8% to 30.7%) in Filipino, 26.7% (CI, 24.1% to 29.5%) in Japanese, 22.4% (CI, 21.1% to 23.7%) in Asian Indian, 17.4% (CI, 15.2% to 19.8%) in Korean, 13.6% (CI, 11.7% to 15.9%) in Vietnamese, and 13.2% (CI, 12.0% to 14.5%) in Chinese Americans.
Body mass index estimates rely on self-reported data.
Substantial heterogeneity in obesity prevalence exists among Asian American subgroups in the United States. Future studies and public health efforts should consider this heterogeneity.
National Heart, Lung, and Blood Institute.
肥胖会增加代谢和心血管疾病的风险,而亚洲成年人的这种风险在较低的体重指数(BMI)阈值下就会出现,比白人成年人更早。由于大多数肥胖估计将所有亚裔美国人合并为一个单一群体,因此尚不清楚亚裔美国人群体中肥胖患病率存在多大差异。
使用标准 BMI 分类和针对亚洲人群的分类来量化美国亚裔成年人亚群中的肥胖患病率。
横断面研究。
美国,2013 年至 2020 年。
分析样本包括美国行为风险因素监测系统调查(2013 年至 2020 年)中 18 岁及以上的 2882158 名成年人。参与者自认为是非西班牙裔白人([NHW] = 2547965 人);非西班牙裔黑人([NHB] = 263136 人);或非西班牙裔亚裔([NHA] = 71057 人),包括印度裔美国人( = 13916 人)、中国人( = 11686 人)、菲律宾裔美国人( = 11815 人)、日本人( = 12473 人)、韩国人( = 3634 人)和越南人( = 2618 人)。
使用标准 BMI 阈值(≥30kg/m)和针对亚洲成年人(≥27.5kg/m)修改的 BMI 阈值计算调整后的年龄和性别后肥胖患病率,基于自我报告的身高和体重。
根据标准分类,调整后的肥胖患病率(NHA 为 11.7%[95%CI,11.2%至 12.2%],NHB 为 39.7%[CI,39.4%至 40.1%],NHW 为 29.4%[CI,29.3%至 29.5%]);菲律宾裔美国人的患病率为 16.8%(CI,15.2%至 18.5%),日本人的患病率为 15.3%(CI,13.2%至 17.5%),印度裔美国人的患病率为 11.2%(CI,10.2%至 12.2%),亚裔美国人的患病率为 8.5%(CI,6.8%至 10.5%),韩国人的患病率为 6.5%(CI,5.5%至 7.5%),中国人的患病率为 6.3%(CI,5.1%至 7.8%),越南人的患病率为 6.3%(CI,5.1%至 7.8%)。使用修改后的标准(BMI≥27.5kg/m)的患病率为 22.4%(CI,21.8%至 23.1%),在所有 NHA 参与者中总体患病率为 28.7%(CI,26.8%至 30.7%),在菲律宾裔美国人中为 28.7%(CI,26.8%至 30.7%),在日本人中为 26.7%(CI,24.1%至 29.5%),在印度裔美国人中为 22.4%(CI,21.1%至 23.7%),在韩国人中为 17.4%(CI,15.2%至 19.8%),在越南人中为 13.6%(CI,11.7%至 15.9%),在中国人中为 13.2%(CI,12.0%至 14.5%)。
体重指数估计依赖于自我报告的数据。
在美国的亚裔美国人亚群中,肥胖患病率存在很大差异。未来的研究和公共卫生工作应考虑到这种差异。
国家心肺血液研究所。